316 related articles for article (PubMed ID: 25213261)
1. Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease.
Deja S; Porebska I; Kowal A; Zabek A; Barg W; Pawelczyk K; Stanimirova I; Daszykowski M; Korzeniewska A; Jankowska R; Mlynarz P
J Pharm Biomed Anal; 2014 Nov; 100():369-380. PubMed ID: 25213261
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic profiling of doxycycline treatment in chronic obstructive pulmonary disease.
Singh B; Jana SK; Ghosh N; Das SK; Joshi M; Bhattacharyya P; Chaudhury K
J Pharm Biomed Anal; 2017 Jan; 132():103-108. PubMed ID: 27697570
[TBL] [Abstract][Full Text] [Related]
3. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases.
Adamko DJ; Nair P; Mayers I; Tsuyuki RT; Regush S; Rowe BH
J Allergy Clin Immunol; 2015 Sep; 136(3):571-580.e3. PubMed ID: 26152317
[TBL] [Abstract][Full Text] [Related]
5. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
[TBL] [Abstract][Full Text] [Related]
6. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
[TBL] [Abstract][Full Text] [Related]
7. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
[No Abstract] [Full Text] [Related]
9. Metabolomics in COPD Acute Respiratory Failure Requiring Noninvasive Positive Pressure Ventilation.
Fortis S; Lusczek ER; Weinert CR; Beilman GJ
Can Respir J; 2017; 2017():9480346. PubMed ID: 29391845
[TBL] [Abstract][Full Text] [Related]
10. Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.
Wang H; Zhang H; Deng P; Liu C; Li D; Jie H; Zhang H; Zhou Z; Zhao YL
BMC Cancer; 2016 Jun; 16():371. PubMed ID: 27356757
[TBL] [Abstract][Full Text] [Related]
11. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
[No Abstract] [Full Text] [Related]
12. Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease.
Diao W; Labaki WW; Han MK; Yeomans L; Sun Y; Smiley Z; Kim JH; McHugh C; Xiang P; Shen N; Sun X; Guo C; Lu M; Standiford TJ; He B; Stringer KA
Int J Chron Obstruct Pulmon Dis; 2019; 14():2015-2025. PubMed ID: 31564849
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the molecular expression profile of non small cell lung carcinoma associated to chronic obstructive pulmonary disease.
Garcia-Lujan R; Conde-Gallego E; Lopez-Ríos F; Martin de Nicolas JL; Sanchez-Céspedes M; García-Quero C; Echave-Sustaeta JM; Lopez-Encuentra A
Histol Histopathol; 2009 Apr; 24(4):417-23. PubMed ID: 19224444
[TBL] [Abstract][Full Text] [Related]
14. Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.
Liu D; Meister M; Zhang S; Vong CI; Wang S; Fang R; Li L; Wang PG; Massion P; Ji X
Respir Res; 2020 Sep; 21(1):242. PubMed ID: 32957957
[TBL] [Abstract][Full Text] [Related]
15. Predictive diagnosis of chronic obstructive pulmonary disease using serum metabolic biomarkers and least-squares support vector machine.
Zheng H; Hu Y; Dong L; Shu Q; Zhu M; Li Y; Chen C; Gao H; Yang L
J Clin Lab Anal; 2021 Feb; 35(2):e23641. PubMed ID: 33141993
[TBL] [Abstract][Full Text] [Related]
16. A metabolomic approach to lung cancer.
Hori S; Nishiumi S; Kobayashi K; Shinohara M; Hatakeyama Y; Kotani Y; Hatano N; Maniwa Y; Nishio W; Bamba T; Fukusaki E; Azuma T; Takenawa T; Nishimura Y; Yoshida M
Lung Cancer; 2011 Nov; 74(2):284-92. PubMed ID: 21411176
[TBL] [Abstract][Full Text] [Related]
17. Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non-small-cell lung cancer.
Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
Int J Chron Obstruct Pulmon Dis; 2016; 11():43-9. PubMed ID: 26766906
[TBL] [Abstract][Full Text] [Related]
18. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
[TBL] [Abstract][Full Text] [Related]
20. Staging research of human lung cancer tissues by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy (HRMAS
Chen W; Lu S; Wang G; Chen F; Bai C
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e232-e238. PubMed ID: 27670847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
